EUVIMEDEUVIMED entdecken
Crossref

Direct Cost of Percutaneous Deep Vein Arterialization: A Retrospective Analysis From a Single Center in Italy

Bruno Migliara, Daniela Cazzato, Cristian Nicoletti, Giovanni Feriani, Nicola Raschellà, Andrea Marcellusi, Chiara Bini

Journal of Critical Limb Ischemia · 2026-06 · 6 (2) · E70-E77

DOI: 10.25270/jcli/clig-2600003 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Critical Limb Ischemia, 2026-06. Verfasst von Bruno Migliara und 6 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

To evaluate health care resource utilization and hospital costs associated with percutaneous deep vein arterialization (pDVA) in patients with chronic limb-threatening ischemia (CLTI) and to estimate the total hospital costs of the treatment pathway leading to limb healing.

Methods

A single-center retrospective cohort study using hospital electronic health records was conducted. Adult patients with Rutherford class 5 or 6 CLTI, ineligible for surgical or endovascular revascularization, who underwent pDVA between March 2019 and August 2021, were included. A cost analysis was conducted from the hospital’s perspective to estimate pDVA-related and follow-up hospital costs from the index procedure to 1-year follow-up.

Results

The analysis included 19 adult patients and a total of 22 limbs not eligible for surgical or endovascular arterial revascularization. The average pDVA hospitalization cost to perform pDVA in a single limb was estimated at €19,997 (US $23,279), compared with a median diagnosis-related group (DRG) reimbursement of €13,325 (US $15,512). Materials accounted for 67.1% of costs, followed by operating room expenses (22.5%) and length of stay (8.4%). At 12 months, 45% of limbs were healed, while during the follow-up 23% underwent amputation. The mean follow-up cost per healed limb was €25,158 (US $29,286); combined with pDVA costs (€19,523 [US $22,727]), the total cost for limb healing was €44,681 (US $52,013). Mean DRG reimbursement for healed limbs was €63,508 (US $73,930), yielding a positive hospital margin of €18,827 (US $21,917).

Conclusions

Although pDVA is associated with high material costs, this single-center exploratory analysis suggests that completing the entire treatment pathway may be economically feasible from the hospital’s perspective.

Zitieren

APA

Migliara, B., Cazzato, D., Nicoletti, C., Feriani, G., Raschellà, N., Marcellusi, A., & Bini, C. (2026). Direct Cost of Percutaneous Deep Vein Arterialization: A Retrospective Analysis From a Single Center in Italy. Journal of Critical Limb Ischemia, 6(2), E70-E77. https://doi.org/10.25270/jcli/clig-2600003

Vancouver

Migliara B, Cazzato D, Nicoletti C, Feriani G, Raschellà N, Marcellusi A, et al. Direct Cost of Percutaneous Deep Vein Arterialization: A Retrospective Analysis From a Single Center in Italy. Journal of Critical Limb Ischemia. 2026;6(2):E70-E77. doi:10.25270/jcli/clig-2600003

BibTeX
@article{Migliara2026,
  author = {Migliara, Bruno and Cazzato, Daniela and Nicoletti, Cristian and Feriani, Giovanni and Raschellà, Nicola and Marcellusi, Andrea and Bini, Chiara},
  title = {Direct Cost of Percutaneous Deep Vein Arterialization: A Retrospective Analysis From a Single Center in Italy},
  journal = {Journal of Critical Limb Ischemia},
  year = {2026},
  volume = {6},
  number = {2},
  pages = {E70--E77},
  doi = {10.25270/jcli/clig-2600003}
}
Kostenlos starten →